This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 173 |
| SARS | 85 |
| CoV-2 | 71 |
| J | 59 |
| Dermatol | 51 |
| Acad | 51 |
| nan | 48 |
| DOI | 42 |
| sha | 31 |
| IL-17 | 30 |
| MIS | 28 |
| teledermatology | 27 |
| IL-23 | 27 |
| C | 27 |
| M. | 25 |
| Dermatology | 24 |
| • | 20 |
| Efficacy | 20 |
| Health | 19 |
| Dr | 18 |
| Janssen | 17 |
| Disease | 17 |
| Coronavirus | 17 |
| ACE2 | 17 |
| MD | 16 |
| Table | 15 |
| ILD | 15 |
| Am | 15 |
| N95 | 14 |
| April | 14 |
| Medical | 14 |
| PCR | 14 |
| Novartis | 14 |
| Pfizer | 14 |
| RTI | 13 |
| ICU | 13 |
| Lilly | 12 |
| American | 12 |
| HS | 11 |
| Care | 11 |
| Celgene | 11 |
| Biobadaderm | 11 |
| MSD | 11 |
| S. | 11 |
| States | 11 |
| Pharma | 11 |
| JAK | 10 |
| CI | 10 |
| Hospital | 10 |
| Italy | 10 |
| J. | 10 |
| Pandemic | 10 |
| MH | 10 |
| R. | 10 |
| RD | 10 |
| United | 10 |
| mg | 10 |
| Gabrin | 9 |
| Crohn | 9 |
| Hydroxychloroquine | 9 |
| Leo | 9 |
| March | 9 |
| FDA | 8 |
| AAD | 8 |
| Anti | 8 |
| Clinical | 8 |
| Dr. | 8 |
| Fernandez | 8 |
| L. | 8 |
| Nieto | 8 |
| US | 8 |
| meta | 8 |
| China | 7 |
| Abbvie | 7 |
| Academy | 7 |
| Almirall | 7 |
| C. | 7 |
| Cilag | 7 |
| Covid-19 | 7 |
| National | 7 |
| Should | 7 |
| TNF | 7 |
| Ustekinumab | 7 |
| Program | 7 |
| H. | 6 |
| Council | 6 |
| Egger | 6 |
| ED | 6 |
| E. | 6 |
| Department | 6 |
| Safety | 6 |
| Begg | 6 |
| Abbott | 6 |
| AbbVie | 6 |
| AGA | 6 |
| IL-12 | 6 |
| IFN | 6 |
| Teledermatology | 6 |
| Inflammatory | 6 |
| Jennifer | 6 |
| Jimenez | 6 |
| K. | 6 |
| Meta | 6 |
| PPE | 6 |
| Reply | 6 |
| Spain | 6 |
| TMPRSS2 | 6 |
| Wuhan | 6 |
| disease-2019 | 6 |
| D. | 5 |
| Grant | 5 |
| García | 5 |
| Daniel | 5 |
| JAAD | 5 |
| Children | 5 |
| Center | 5 |
| BIOBADADERM | 5 |
| II | 5 |
| Patient | 5 |
| Jane | 5 |
| New | 5 |
| dupilumab | 5 |
| Patients | 5 |
| Pernio | 5 |
| Risk | 5 |
| Rivera | 5 |
| doc_id | 5 |
| Kels | 5 |
| Inpatient | 4 |
| G. | 4 |
| Global | 4 |
| Herrera | 4 |
| I. | 4 |
| King | 4 |
| John | 4 |
| June | 4 |
| Kawasaki | 4 |
| Española | 4 |
| López | 4 |
| F. | 4 |
| Damsky | 4 |
| Editor | 4 |
| Dear | 4 |
| Danielle | 4 |
| NLR | 4 |
| Control | 4 |
| CoV | 4 |
| Cauhe | 4 |
| COVID | 4 |
| Brett | 4 |
| Amgen | 4 |
| -0.002 | 4 |
| May | 4 |
| CRS | 4 |
| Ortega | 4 |
| Syndrome | 4 |
| PICU | 4 |
| mucositis | 4 |
| anti | 4 |
| York | 4 |
| Y. | 4 |
| Wu | 4 |
| William | 4 |
| Wambier | 4 |
| Verona | 4 |
| Use | 4 |
| Universitario | 4 |
| pemphigus | 4 |
| Spanish | 4 |
| S1 | 4 |
| Residents | 4 |
| Resident | 4 |
| Registry | 4 |
| RNA | 4 |
| Quijano | 4 |
| Psoriasis | 4 |
| Prevention | 4 |
| Phase | 4 |
| Peterson | 4 |
| SIR | 4 |
| Diego | 3 |
| FAAD | 3 |
| Dupilumab | 3 |
| Donoso | 3 |
| Collaboration | 3 |
| Descalzo | 3 |
| Dermatoethicist | 3 |
| Dermatitis | 3 |
| David | 3 |
| College | 3 |
| Fair | 3 |
| Homeless | 3 |
| February | 3 |
| Figure | 3 |
| Guselkumab | 3 |
| Healthcare | 3 |
| Heart | 3 |
| Hospitalized | 3 |
| Hsiao | 3 |
| IL-13 | 3 |
| Ilana | 3 |
| Impact | 3 |
| Journal | 3 |
| Chen | 3 |
| Cochrane | 3 |
| B. | 3 |
| Chat | 3 |
| Assessment | 3 |
| LR | 3 |
| 0.002 | 3 |
| 8) | 3 |
| A | 3 |
| AB | 3 |
| ACD | 3 |
| Adalimumab | 3 |
| Alejo | 3 |
| Allocation | 3 |
| Application | 3 |
| Association | 3 |
| Centers | 3 |
| Benjamin | 3 |
| Blasco | 3 |
| Brazil | 3 |
| Burgos | 3 |
| CD | 3 |
| CHRONOS | 3 |
| COV-2 | 3 |
| Cardiovascular | 3 |
| Carlos | 3 |
| Carretero | 3 |
| Juan | 3 |
| T. | 3 |
| LRTIs | 3 |
| SOLO | 3 |
| Scarce | 3 |
| Study | 3 |
| Survey | 3 |
| T | 3 |
| UCB | 3 |
| URI | 3 |
| University | 3 |
| Velasco | 3 |
| Vilar | 3 |
| World | 3 |
| briakinumab | 3 |
| interleukin-12/23 | 3 |
| ixekizumab | 3 |
| key | 3 |
| kg | 3 |
| lesion(s | 3 |
| multicentre | 3 |
| prednisone | 3 |
| qw | 3 |
| reticularis | 3 |
| secukinumab | 3 |
| α | 3 |
| Lebwohl | 3 |
| Sara | 3 |
| azithromycin | 3 |
| Rosman | 3 |
| Organization | 3 |
| Letter | 3 |
| Response | 3 |
| Livedo | 3 |
| Llamas | 3 |
| MERS | 3 |
| Marzano | 3 |
| Masks | 3 |
| Multisystem | 3 |
| N. | 3 |
| Nathan | 3 |
| Occupational | 3 |
| MyChart | 3 |
| P. | 3 |
| Pneumonia | 3 |
| Resources | 3 |
| Randomized | 3 |
| RCTs | 3 |
| QW | 3 |
| Research | 3 |
| PRISMA | 3 |
| PIONEER | 3 |
| PEH | 3 |
| HIV | 2 |
| IL-1 | 2 |
| IL | 2 |
| I | 2 |
| Hussey | 2 |
| Host | 2 |
| Hidradenitis | 2 |
| Healthy | 2 |
| Haya | 2 |
| HNS=4 | 2 |
| HNS=3 | 2 |
| HNS | 2 |
| Gallego | 2 |
| HCWs | 2 |
| HCQ | 2 |
| Gustavo | 2 |
| Guidelines | 2 |
| Guhan | 2 |
| Guarino | 2 |
| Goren | 2 |
| Gomez | 2 |
| Gisondi | 2 |
| Geneva | 2 |
| Gelfand | 2 |
| IL-23-specific | 2 |
| Fundación | 2 |
| IL-12/23 | 2 |
| MDBGN | 2 |
| IL-4 | 2 |
| Justin | 2 |
| Management | 2 |
| Major | 2 |
| MK-3222 | 2 |
| Flórez | 2 |
| Lee | 2 |
| Lan | 2 |
| LEO | 2 |
| Kyla | 2 |
| Kevin | 2 |
| Kearns | 2 |
| Kansal | 2 |
| KD | 2 |
| July | 2 |
| IL-6 | 2 |
| Joel | 2 |
| Jashin | 2 |
| Janus | 2 |
| JAKi | 2 |
| Interval | 2 |
| Institute | 2 |
| Infectious | 2 |
| Infections | 2 |
| Induction | 2 |
| India | 2 |
| Immune | 2 |
| IRB | 2 |
| Frew | 2 |
| Chilblain | 2 |
| Feagan | 2 |
| Cancer | 2 |
| Botella | 2 |
| Biogen | 2 |
| Biobank | 2 |
| Belló | 2 |
| Belinchón | 2 |
| Baniandrés | 2 |
| Balding | 2 |
| Background | 2 |
| BA | 2 |
| Autoxidation | 2 |
| Atopic | 2 |
| Associated | 2 |
| Angeli | 2 |
| Andy | 2 |
| America | 2 |
| Agency | 2 |
| Agencia | 2 |
| Adolescents | 2 |
| Administration | 2 |
| Activities | 2 |
| Acosta | 2 |
| Academic | 2 |
| Academia | 2 |
| APD | 2 |
| Margaret | 2 |
| CSF | 2 |
| Cardiology | 2 |
| Ethics | 2 |
| Carrascosa | 2 |
| Estrada | 2 |
| Estebaranz | 2 |
| Epidemiology | 2 |
| Embase | 2 |
| Elston | 2 |
| Eloise | 2 |
| E&M | 2 |
| Donovan | 2 |
| Diseases | 2 |
| Dirk | 2 |
| Director | 2 |
| Dictionary | 2 |
| Dermatología | 2 |
| Dermatologists | 2 |
| Daudén | 2 |
| DIGA | 2 |
| Cycle | 2 |
| Cueva | 2 |
| Courtney | 2 |
| Contact | 2 |
| Code | 2 |
| Chinese | 2 |
| Characteristics | 2 |
| Ceballos | 2 |
| Cavanaugh | 2 |
| Mar | 2 |
| BMI | 2 |
| Marilyn | 2 |
| UK | 2 |
| Wall | 2 |
| WHO | 2 |
| W. | 2 |
| Vivian | 2 |
| Vipawee | 2 |
| Verónica | 2 |
| Venereología | 2 |
| Valentina | 2 |
| Uppal | 2 |
| Unit | 2 |
| Ultraviolet | 2 |
| UVC | 2 |
| U.S. | 2 |
| Student | 2 |
| Tween | 2 |
| Trials | 2 |
| Treatment | 2 |
| Torres | 2 |
| Time | 2 |
| Tildrakizumab | 2 |
| Therapy | 2 |
| Team | 2 |
| Tan | 2 |
| Tables | 2 |
| Sáez | 2 |
| Systematic | 2 |
| Winthrop | 2 |
| Workers | 2 |
| Yin | 2 |
| baricitinib | 2 |
| Marina | 2 |
| Ángeles | 2 |
| Ángel | 2 |
| tildrakizumab | 2 |
| simplex | 2 |
| risankizumab | 2 |
| reSURFACE | 2 |
| q2w | 2 |
| protein | 2 |
| papillitis | 2 |
| nonmaleficence | 2 |
| nasopharyngitis | 2 |
| methotrexate | 2 |
| medicine | 2 |
| i.v | 2 |
| histopathological | 2 |
| exanthem | 2 |
| etanercept | 2 |
| eVisits | 2 |
| eConsults | 2 |
| clinicaltrials.gov | 2 |
| calcineurin | 2 |
| bromhexine | 2 |
| brodalumab | 2 |
| brazikumab | 2 |
| Suppurativa | 2 |
| Wan | 2 |
| Street | 2 |
| Mucocutaneous | 2 |
| Present | 2 |
| Piel | 2 |
| Peset | 2 |
| Peggy | 2 |
| Pediatric | 2 |
| Patricia | 2 |
| Patel | 2 |
| PSUMMIT | 2 |
| PHOENIX | 2 |
| Oyola | 2 |
| Neera | 2 |
| Natalia | 2 |
| Monoclonal | 2 |
| Productos | 2 |
| Ministry | 2 |
| Miguel | 2 |
| Methods | 2 |
| Menéndez | 2 |
| Medicines | 2 |
| Medicine | 2 |
| Medicamentos | 2 |
| MedDRA | 2 |
| McCoy | 2 |
| Massó | 2 |
| Stoff | 2 |
| Matching | 2 |
| Price | 2 |
| Northwell | 2 |
| Products | 2 |
| Salvatore | 2 |
| Society | 2 |
| Shin | 2 |
| Shi | 2 |
| Shelley | 2 |
| Shari | 2 |
| Severe | 2 |
| Schadt | 2 |
| Sanitarios | 2 |
| Sandborn | 2 |
| Sana | 2 |
| Samimi | 2 |
| Samantha | 2 |
| Smith | 2 |
| Sahuquillo | 2 |
| Ruggiero | 2 |
| Rodríguez | 2 |
| Reviews | 2 |
| Residency | 2 |
| Regulatory | 2 |
| Recommendations | 2 |
| Raef | 2 |
| Rachel | 2 |
| PubMed | 2 |
| S6 | 2 |
| Ha | 1 |
| HCZ | 1 |
| HNS=2 | 1 |
| HNS=3v | 1 |
| HSV-1 | 1 |
| Hao | 1 |
| Haenszel | 1 |
| Haley | 1 |
| Hamzavi | 1 |
| Handbook | 1 |
| Hashimoto | 1 |
| Hastings | 1 |
| HCV | 1 |
| Gregorio | 1 |
| HBV | 1 |
| Gómez | 1 |
| Gynecology | 1 |
| Group | 1 |
| Grantee | 1 |
| Gran | 1 |
| Graham | 1 |
| Grace | 1 |
| GpSkin | 1 |
| Government | 1 |
| Gordon | 1 |
| Gottlieb | 1 |
| Healing | 1 |
| Head | 1 |
| Immunogenicity | 1 |
| Heather | 1 |
| IL17 | 1 |
| Gondar | 1 |
| Immunosuppressants | 1 |
| Immunology | 1 |
| Immediate | 1 |
| Imbalanced | 1 |
| Iltefat | 1 |
| IgM | 1 |
| Iacono | 1 |
| IRF | 1 |
| IQR | 1 |
| IP10 | 1 |
| IP | 1 |
| IL-23p19 | 1 |
| Henry | 1 |
| IL-23A | 1 |
| IL-2 | 1 |
| IL-17eproducing | 1 |
| IL)-12/23 | 1 |
| IIb | 1 |
| ICD | 1 |
| Hylwa | 1 |
| Humans | 1 |
| Humanity | 1 |
| Hruza | 1 |
| Histopathology | 1 |
| Hepatol | 1 |
| 1 | |
| FDA-49 | 1 |
| Gomis | 1 |
| Faramarz | 1 |
| Forward | 1 |
| Food | 1 |
| First | 1 |
| Fig1 | 1 |
| Fig.2 | 1 |
| Fig | 1 |
| Festa | 1 |
| Ferrán | 1 |
| Ferreira | 1 |
| Feng | 1 |
| Femia | 1 |
| Feinstein | 1 |
| Fang | 1 |
| Framework | 1 |
| Falo | 1 |
| Failure | 1 |
| Factors | 1 |
| Factor | 1 |
| Facial | 1 |
| Facepiece | 1 |
| Fabio | 1 |
| Fabbrocini | 1 |
| FGF | 1 |
| Inc | 1 |
| F | 1 |
| Experience | 1 |
| Foundation | 1 |
| Freeman | 1 |
| Goldminz | 1 |
| Genao | 1 |
| Goff | 1 |
| Goal | 1 |
| Glaxo | 1 |
| Giuseppe | 1 |
| Girolomoni | 1 |
| Giglio | 1 |
| Gibbon | 1 |
| Gianluigi | 1 |
| Giampiero | 1 |
| Geskin | 1 |
| George | 1 |
| Genovese | 1 |
| Gastroenterology | 1 |
| Fumarates | 1 |
| Gastroenterol | 1 |
| Garg | 1 |
| Galván | 1 |
| Gallo | 1 |
| Galderma | 1 |
| Gabriella | 1 |
| Gabel | 1 |
| Gabbi | 1 |
| GMCSF | 1 |
| GM | 1 |
| GCSF | 1 |
| G | 1 |
| Implementation | 1 |
| Laboratory | 1 |
| Inc. | 1 |
| Latency | 1 |
| MPH | 1 |
| MMS | 1 |
| MIS-88 | 1 |
| MHV | 1 |
| MEDI2070 | 1 |
| MCP1 | 1 |
| MCC | 1 |
| M | 1 |
| Lupus | 1 |
| Lucia | 1 |
| Lu | 1 |
| Louis | 1 |
| Lotti | 1 |
| London | 1 |
| Loh | 1 |
| Lo | 1 |
| Liver | 1 |
| Little | 1 |
| Litchman | 1 |
| Lipner | 1 |
| Lin | 1 |
| Lim | 1 |
| Lihong | 1 |
| Li | 1 |
| Lessons | 1 |
| Leonardi | 1 |
| LeoPharma | 1 |
| MSHS | 1 |
| Mack | 1 |
| Madrid | 1 |
| McGee | 1 |
| Middle | 1 |
| Microneedles | 1 |
| Microneedle | 1 |
| Micol | 1 |
| Micic | 1 |
| Michael | 1 |
| Mice | 1 |
| Melissa | 1 |
| Megan | 1 |
| Medicare | 1 |
| Mclnne | 1 |
| McMahon | 1 |
| Mauskar | 1 |
| Maintenance | 1 |
| Mattia | 1 |
| Matthew | 1 |
| Maternal | 1 |
| Marta | 1 |
| Mark | 1 |
| Maria | 1 |
| Margo | 1 |
| Marcelo | 1 |
| Manuscript | 1 |
| Mantel | 1 |
| Mansh | 1 |
| Manalo | 1 |
| Latin | 1 |
| Larisa | 1 |
| Inequality | 1 |
| Langone | 1 |
| Jean | 1 |
| Jansenn | 1 |
| Janowska | 1 |
| Jaime | 1 |
| Jacobs | 1 |
| Jacob | 1 |
| JC | 1 |
| Iviensan | 1 |
| Itisha | 1 |
| Items | 1 |
| Israel | 1 |
| Irvine | 1 |
| Intravenous | 1 |
| Interventions | 1 |
| Interstitial | 1 |
| International | 1 |
| Interleukin-4 | 1 |
| Interleukin | 1 |
| Interferonopathy | 1 |
| Instrumental | 1 |
| Institutions | 1 |
| Institutional | 1 |
| Institutes | 1 |
| Innate | 1 |
| Initial | 1 |
| Information | 1 |
| Infection | 1 |
| Jefferson | 1 |
| Jiade | 1 |
| Jie | 1 |
| Kolodney | 1 |
| Landscape | 1 |
| Labs | 1 |
| Events | 1 |
| LOTUS | 1 |
| LIBERTY | 1 |
| Krysta | 1 |
| Krueger | 1 |
| Kroshinksy | 1 |
| Kristen | 1 |
| Krishna | 1 |
| Koschitzky | 1 |
| Kong | 1 |
| Kolitz | 1 |
| Joao | 1 |
| Kira | 1 |
| Khattri | 1 |
| Keywords | 1 |
| Katharina | 1 |
| Karagounis | 1 |
| Kaffenberger | 1 |
| KOH | 1 |
| Jose | 1 |
| Jonathan | 1 |
| Joint | 1 |
| Johnson | 1 |
| Johns | 1 |
| Evidence | 1 |
| Dauden | 1 |
| Evaluation | 1 |
| Eun | 1 |
| Betensky | 1 |
| Benito | 1 |
| Bell | 1 |
| Bayes | 1 |
| Batista | 1 |
| Bassi | 1 |
| Basil | 1 |
| Based | 1 |
| Barrios | 1 |
| Barr | 1 |
| Baricitinib | 1 |
| Baric | 1 |
| Ballescá | 1 |
| BI | 1 |
| B | 1 |
| Avancini | 1 |
| Automated | 1 |
| Autoimmune | 1 |
| Austin | 1 |
| Atwater | 1 |
| Attacks | 1 |
| Atsushi | 1 |
| Astellas | 1 |
| ArticleID/10252 | 1 |
| Arrones | 1 |
| Arnone | 1 |
| Ari | 1 |
| Beth | 1 |
| Bias | 1 |
| Bickers | 1 |
| Brodell | 1 |
| COVID-19-positive | 1 |
| COVID-19)-United | 1 |
| COVID-101 | 1 |
| COVI-19 | 1 |
| CNI | 1 |
| CMS | 1 |
| CL | 1 |
| CADMUS | 1 |
| CA | 1 |
| Brumfiel | 1 |
| Bruce | 1 |
| Bromhexine | 1 |
| Brodalumab | 1 |
| Biologic | 1 |
| Brittney | 1 |
| Briakinumab | 1 |
| Bret | 1 |
| Boas | 1 |
| Blauvelt | 1 |
| Blanca | 1 |
| Birabaharan | 1 |
| Biotech | 1 |
| Biostat | 1 |
| Biorender.com | 1 |
| Biology | 1 |
| Biologics | 1 |
| Arcangeli | 1 |
| Arabia | 1 |
| Apremilast | 1 |
| A. | 1 |
| Aerosol | 1 |
| Actives | 1 |
| Accountability | 1 |
| Accessed | 1 |
| Abstract | 1 |
| Aasi | 1 |
| ARBs | 1 |
| AHAR | 1 |
| AEs | 1 |
| AD | 1 |
| ACE)-inhibitors | 1 |
| ACE | 1 |
| @WambierMD | 1 |
| Agata | 1 |
| > | 1 |
| 9lewc581 | 1 |
| 9622(09)00603 | 1 |
| 7d5352941154f2803c2b6cc2e22041dc492f401e | 1 |
| 7d1286c85ba27f06fb44a9216f62f28b42e0d269 | 1 |
| 79.4%(p<0.00001 | 1 |
| 370c1745232d28ee7bbf3fa762a61efd24262afa | 1 |
| 34804d8dd14a3514689d2e1c0759ff9506001b46 | 1 |
| 2b1327fd0af9b26e2fb91b54bfe7c473d8ac3ed8 | 1 |
| -furuncle | 1 |
| -The | 1 |
| Misha | 1 |
| African | 1 |
| Agility | 1 |
| Approach | 1 |
| Amit | 1 |
| Applied | 1 |
| Antonio | 1 |
| Antibody | 1 |
| Answer | 1 |
| Annual | 1 |
| Angiogenesis | 1 |
| Angela | 1 |
| Anesthesia | 1 |
| Andrew | 1 |
| Andrea | 1 |
| Analysis | 1 |
| Analyses | 1 |
| Ametrano | 1 |
| Ahmed | 1 |
| Americans | 1 |
| Ambulatory | 1 |
| Amber | 1 |
| Altus | 1 |
| Alsina | 1 |
| Alliance | 1 |
| Allergic | 1 |
| Alisa | 1 |
| Alhusayen | 1 |
| Albert | 1 |
| Akiyama | 1 |
| Akihiro | 1 |
| COVID-19-related | 1 |
| COVID-54 | 1 |
| CPT | 1 |
| Dhurat | 1 |
| Drug | 1 |
| Drs | 1 |
| Doval | 1 |
| Dose | 1 |
| Division | 1 |
| Disparities | 1 |
| Disinfection | 1 |
| Dis | 1 |
| Directors | 1 |
| Direct | 1 |
| Dini | 1 |
| Diana | 1 |
| Devon | 1 |
| Dutasteride | 1 |
| Detection | 1 |
| Details | 1 |
| Denise | 1 |
| Dengue | 1 |
| Del | 1 |
| Dejan | 1 |
| Dedee | 1 |
| December | 1 |
| Deaconess | 1 |
| Data | 1 |
| Das | 1 |
| Darrell | 1 |
| Dunnick | 1 |
| Dysregulated | 1 |
| DPDS | 1 |
| Engineering | 1 |
| Ethical | 1 |
| Estimate | 1 |
| Esther | 1 |
| Esteban | 1 |
| Erythema | 1 |
| Era | 1 |
| Equipment | 1 |
| Epub | 1 |
| Epstein | 1 |
| Epiphenomenon | 1 |
| Englewood | 1 |
| England | 1 |
| Emitter | 1 |
| Dysregulation | 1 |
| Emergency | 1 |
| Emanuel | 1 |
| Elysha | 1 |
| Eli | 1 |
| Ed | 1 |
| Eczema | 1 |
| Economic | 1 |
| Ebola | 1 |
| East | 1 |
| Early | 1 |
| EPIDERM | 1 |
| E | 1 |
| Daniela | 1 |
| DIC | 1 |
| CSPA | 1 |
| Chart | 1 |
| Cochran | 1 |
| Coalition | 1 |
| CoV-1 | 1 |
| Clin | 1 |
| Classification | 1 |
| Classic | 1 |
| City | 1 |
| Christen | 1 |
| Chisolm | 1 |
| Child | 1 |
| Chilblains | 1 |
| Cheeley | 1 |
| Charleston | 1 |
| Cohen | 1 |
| Characterization | 1 |
| Characterisation | 1 |
| Chakravarthi | 1 |
| Centocor | 1 |
| Celiac | 1 |
| Cases | 1 |
| Carvajal | 1 |
| Carolina | 1 |
| Carmen | 1 |
| Canaria | 1 |
| Caitlin | 1 |
| Cabrera | 1 |
| CodingIntel | 1 |
| Combat | 1 |
| D-2 | 1 |
| Cory | 1 |
| D-1 | 1 |
| Cyro | 1 |
| Curriculum | 1 |
| Cucchiara | 1 |
| Criteria | 1 |
| Cristina | 1 |
| Crisis | 1 |
| Covid | 1 |
| Coverage | 1 |
| Cov-2 | 1 |
| Course | 1 |
| Cosimo | 1 |
| Coronaviruses | 1 |
| Commentary | 1 |
| Coronavirus-19 | 1 |
| Core | 1 |
| Conventional | 1 |
| Context | 1 |
| Contents | 1 |
| Consultations | 1 |
| Consultation | 1 |
| Congress | 1 |
| Comprehensive | 1 |
| Company | 1 |
| Common | 1 |
| Committee | 1 |
| Minkis | 1 |
| Topical | 1 |
| Mitanjali | 1 |
| Tatyana | 1 |
| cord-034195-yiv8rp7y | 1 |
| cord-011451-nnunjora | 1 |
| clshw9v2 | 1 |
| chilblains | 1 |
| chi | 1 |
| chemoattractant | 1 |
| ccqne6nu | 1 |
| c88tkbnz | 1 |
| c41c1db843dbab2748de47a291e222508529815e | 1 |
| c41260292646543a7bf692b85aa7ae1383eb5ba9 | 1 |
| c12b8a4b445e1b4d1649b523d93dc54d6e0e4a8e | 1 |
| c02992571a8d15b82e8beeb4332b5caead05b346 | 1 |
| board | 1 |
| blain | 1 |
| b188599b1cbcab282a8454bfec98b9aade5f508b | 1 |
| b063506cc7f163b787bc6e5a21022970405ba98c | 1 |
| areata | 1 |
| aq80vius | 1 |
| antibody | 1 |
| ankylosing | 1 |
| andpsoriatic | 1 |
| aminosalicylates | 1 |
| alopecia | 1 |
| adalimumab | 1 |
| ad5dd2193095b5ede55e2968d10c5c2541a5ccf7 | 1 |
| aacc7792cb887fed5288ee988411990d034e78a7 | 1 |
| a9qd3xdr | 1 |
| cord-252521-m7asfqva | 1 |
| cord-256565 | 1 |
| cord-262311-vdbk50pl | 1 |
| data | 1 |
| f0d9ad99208933227defa5d58ce4bf9d51f820f8 | 1 |
| egvdvvtx | 1 |
| education | 1 |
| ecsa83kf | 1 |
| eca7d5518b648c6d9ae8fb604aa4f9d496f68bb8 | 1 |
| eace36ee3b29470cb1a737d9958a31305ed9c186 | 1 |
| eReluctant | 1 |
| eDr | 1 |
| eConsult | 1 |
| dermoscopy | 1 |
| dermatology | 1 |
| del | 1 |
| d7eec1de0d7b259ead7330215127e5dc4ef4b5d9 | 1 |
| cord-274517 | 1 |
| d660bfad8657672cf13d598a29598afae78b6a75 | 1 |
| cytomegalovirus | 1 |
| cord-336450 | 1 |
| cord-329353 | 1 |
| cord-323241 | 1 |
| cord-309914 | 1 |
| cord-303800-h3lvbldz | 1 |
| cord-302993-t4quwfva | 1 |
| cord-301478-j4b2534p | 1 |
| cord-296013 | 1 |
| cord-285030-ecsa83kf | 1 |
| cord-274750-fynxciwg | 1 |
| a297e8da8bd39c8cedf2a4a43e02684c64bdf7d2 | 1 |
| a1fb47538ba2f34ec43d4ab1ee88ac12e7ebb5d6 | 1 |
| Zoster | 1 |
| Torello | 1 |
| UT | 1 |
| USA | 1 |
| URTI | 1 |
| Tzank | 1 |
| Type | 1 |
| Two | 1 |
| Tsai | 1 |
| Trinidad | 1 |
| Trial | 1 |
| Treatments | 1 |
| Trager | 1 |
| Torralba | 1 |
| Toes | 1 |
| VEGFA | 1 |
| Title | 1 |
| Timeline | 1 |
| Tiffany | 1 |
| Third | 1 |
| Thiers | 1 |
| Theodora | 1 |
| Th1 | 1 |
| Testing | 1 |
| Terui | 1 |
| Teresa | 1 |
| Telemedicine | 1 |
| Techniques | 1 |
| V. | 1 |
| Vaccine | 1 |
| Zoom | 1 |
| Wyeth | 1 |
| Zippin | 1 |
| Zheng | 1 |
| Zhejiang | 1 |
| Zeitouni | 1 |
| Zaza | 1 |
| Z. | 1 |
| Yu | 1 |
| Yousaf | 1 |
| Young | 1 |
| Yamada | 1 |
| Xu | 1 |
| Xia | 1 |
| Wright | 1 |
| Vaccines | 1 |
| Wound | 1 |
| Wood | 1 |
| Whole-62 | 1 |
| Wei | 1 |
| Vincenzo | 1 |
| Villas | 1 |
| Victoria | 1 |
| Version | 1 |
| Veerabagu | 1 |
| Vaño | 1 |
| Vamshi | 1 |
| Valle | 1 |
| fp8phk0p | 1 |
| fulltext | 1 |
| fynxciwg | 1 |
| pharyngodynia | 1 |
| sharps | 1 |
| s.c | 1 |
| ruxolitinib | 1 |
| rt-45 | 1 |
| review | 1 |
| retiform | 1 |
| purpura | 1 |
| pt2u6608 | 1 |
| psoriasis | 1 |
| prophylaxis | 1 |
| population | 1 |
| pjdedw7w | 1 |
| person | 1 |
| sub-60 | 1 |
| pernio | 1 |
| perivascular | 1 |
| pceenwb6 | 1 |
| pandemic | 1 |
| p=0.0015 | 1 |
| oropharyngitis | 1 |
| org | 1 |
| oj76ol8v | 1 |
| nº | 1 |
| nonemergent | 1 |
| nnunjora | 1 |
| nhchc.org | 1 |
| sore | 1 |
| swex393r | 1 |
| nd | 1 |
| xerosis | 1 |
| ≥100.4 | 1 |
| ≤18 | 1 |
| Álvarez | 1 |
| ± | 1 |
| ° | 1 |
| ® | 1 |
| zygomatic | 1 |
| yiv8rp7y | 1 |
| yang | 1 |
| y3a1qyi9 | 1 |
| xsroivzj | 1 |
| xg176mi7 | 1 |
| x688qqdr | 1 |
| syndromecoronavirus | 1 |
| wt>100 | 1 |
| vy5c7411 | 1 |
| vlwlgp82 | 1 |
| vivo | 1 |
| vdbk50pl | 1 |
| ustekinumab | 1 |
| urys21ry | 1 |
| 1 | |
| tofacitinib | 1 |
| targetoid | 1 |
| t9df8vhc | 1 |
| t4quwfva | 1 |
| netlike | 1 |
| nclk7bbo | 1 |
| golimumab | 1 |
| hyperimmune | 1 |
| j.jaad.2020.04.016 | 1 |
| j.jaad.2020.03.046 | 1 |
| j.jaad.2020.02.031 | 1 |
| isgcm4lj | 1 |
| interleukin-4 | 1 |
| interleukin-17 | 1 |
| institutional | 1 |
| infectiosum | 1 |
| infectioninduced | 1 |
| index.html | 1 |
| immunomodulator | 1 |
| immunofluorescent | 1 |
| hydrochloride | 1 |
| j.jaad.2020.04.096 | 1 |
| https://www.jaad.org/article/S0190-9622(09)00602-1/fulltext | 1 |
| https://www.jaad | 1 |
| https://www.epicentro.iss.it | 1 |
| https://www.azero.veneto.it/-/emergenza-coronavirus | 1 |
| https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019 | 1 |
| http://demo.istat.it | 1 |
| house | 1 |
| hospital-74 | 1 |
| histopathologic | 1 |
| herpes | 1 |
| h7kihj9w | 1 |
| h3lvbldz | 1 |
| j.jaad.2020.04.078 | 1 |
| j.jaad.2020.04.112 | 1 |
| n=257,353 | 1 |
| j.jaad.2020.10.042 | 1 |
| mycobacterial | 1 |
| morbilliform | 1 |
| monocyte | 1 |
| microneedle | 1 |
| mean=10.7 | 1 |
| mAb | 1 |
| m7asfqva | 1 |
| kodachrome | 1 |
| j4b2534p | 1 |
| j10n38ah | 1 |
| j.jaad.2020.10.084 | 1 |
| j.jaad.2020.10.046 | 1 |
| j.jaad.2020.08.054 | 1 |
| j.jaad.2020.04.142 | 1 |
| j.jaad.2020.08.026 | 1 |
| j.jaad.2020.07.132 | 1 |
| j.jaad.2020.07.120 | 1 |
| j.jaad.2020.07.086 | 1 |
| j.jaad.2020.06.983 | 1 |
| j.jaad.2020.06.1008 | 1 |
| j.jaad.2020.06.063 | 1 |
| j.jaad.2020.05.126 | 1 |
| j.jaad.2020.05.077 | 1 |
| j.jaad.2020.05.054 | 1 |
| j.jaad.2020.05.048 | 1 |
| j.jaad.2020.05.035 | 1 |
| Taylor | 1 |
| Tatiana | 1 |
| Miyamoto | 1 |
| Tannenbaum | 1 |
| Placebo | 1 |
| Pivotal | 1 |
| Pisa | 1 |
| Piccolo | 1 |
| Physician | 1 |
| Photograph | 1 |
| Phenomenon | 1 |
| Pharmacokinetics | 1 |
| Petukhova | 1 |
| Peto | 1 |
| Petechial | 1 |
| Personal | 1 |
| Pearson | 1 |
| Paulo | 1 |
| Paula | 1 |
| Paul | 1 |
| Patrì | 1 |
| Papp | 1 |
| Paolo | 1 |
| Palmoplantar | 1 |
| Pai | 1 |
| PROSPERO | 1 |
| PNA | 1 |
| PKA | 1 |
| PEARL | 1 |
| PDGF | 1 |
| PDE4 | 1 |
| Plaque | 1 |
| Policy | 1 |
| Potential | 1 |
| Pustulosis | 1 |
| Rebecca | 1 |
| Raquel | 1 |
| Randy | 1 |
| Raed | 1 |
| Racial | 1 |
| Rachita | 1 |
| RTIs | 1 |
| RT | 1 |
| RCT | 1 |
| Queens | 1 |
| Qiannan | 1 |
| P＜0.05 | 1 |
| Publishes-94 | 1 |
| Practices | 1 |
| Public | 1 |
| PsA | 1 |
| Providers | 1 |
| Provider | 1 |
| Protocol | 1 |
| Protective | 1 |
| Process | 1 |
| Prior | 1 |
| Princesa | 1 |
| Primates | 1 |
| Prieto | 1 |
| Press | 1 |
| PCRconfirmed | 1 |
| P<0 | 1 |
| Ozog | 1 |
| Mª | 1 |
| Nathalie | 1 |
| Nat | 1 |
| Nasopharyngitis | 1 |
| Napolitano | 1 |
| Naik | 1 |
| NYU | 1 |
| NRMP | 1 |
| NPF | 1 |
| NJ | 1 |
| NHS=3 | 1 |
| NFAT | 1 |
| N-95 | 1 |
| Mytrang | 1 |
| Nemoto | 1 |
| Mycobacterium | 1 |
| Muzumdar | 1 |
| Murrell | 1 |
| Multiple | 1 |
| Mowad | 1 |
| Movement | 1 |
| Morgan | 1 |
| Moreno | 1 |
| Monroig | 1 |
| Monica | 1 |
| Molly | 1 |
| Mobile | 1 |
| Negrín | 1 |
| Neta | 1 |
| Outpatient | 1 |
| Olbricht | 1 |
| Outcomes | 1 |
| Oscar | 1 |
| Ortho | 1 |
| Orsola | 1 |
| Options | 1 |
| Optimum | 1 |
| Ophthalmology | 1 |
| Operations | 1 |
| Operating | 1 |
| Onteniente | 1 |
| Oliver | 1 |
| Oliva | 1 |
| Obstetrics | 1 |
| Neutrophil | 1 |
| Objective | 1 |
| ORION | 1 |
| O. | 1 |
| Nursing | 1 |
| Novel | 1 |
| Northern | 1 |
| Noonan | 1 |
| Noninfectious | 1 |
| None | 1 |
| Nonadherent | 1 |
| Non | 1 |
| Nghiem | 1 |
| Reck | 1 |
| Reeder | 1 |
| Regimens | 1 |
| Shortages | 1 |
| Statement | 1 |
| Stanford | 1 |
| Srinivas | 1 |
| Specialty | 1 |
| Southwestern | 1 |
| South | 1 |
| Sonal | 1 |
| Software | 1 |
| Sofen | 1 |
| Silva | 1 |
| Sign | 1 |
| Sicco | 1 |
| Shintaro | 1 |
| Stoj | 1 |
| Shinjita | 1 |
| Shelters | 1 |
| Sheet | 1 |
| Shaw | 1 |
| Sharon | 1 |
| Shah | 1 |
| Severi | 1 |
| Sethy | 1 |
| Service | 1 |
| Sergio | 1 |
| Sergey | 1 |
| Self | 1 |
| Stevens | 1 |
| Store | 1 |
| Screening | 1 |
| Surgeon | 1 |
| Taltz | 1 |
| Taback | 1 |
| TCS | 1 |
| TCIs | 1 |
| Systems | 1 |
| Systemics | 1 |
| System | 1 |
| Suzanne | 1 |
| Surya | 1 |
| Survival | 1 |
| Surgery | 1 |
| Surgeons | 1 |
| Suraj | 1 |
| Streptococcus | 1 |
| Summary | 1 |
| Sumaira | 1 |
| Suicide | 1 |
| Successful | 1 |
| Subjects | 1 |
| Subgroup | 1 |
| Subcutaneous | 1 |
| Suarez | 1 |
| Su | 1 |
| Strunk | 1 |
| Strunck | 1 |
| Stroke | 1 |
| Screenshot | 1 |
| Scientific | 1 |
| Reich | 1 |
| Rheumatologic | 1 |
| Room | 1 |
| Rojek | 1 |
| Rodriguez | 1 |
| Robert | 1 |
| Riyadh | 1 |
| Ritchlin | 1 |
| Risankizumab | 1 |
| Rigel | 1 |
| Riera | 1 |
| Richard | 1 |
| Rheumatology | 1 |
| Rheumatologist | 1 |
| Rheumatol | 1 |
| Rossi | 1 |
| Reynolds | 1 |
| Review | 1 |
| Rev | 1 |
| Reticularis | 1 |
| Respite | 1 |
| Respiratory | 1 |
| Respirators | 1 |
| Reporting | 1 |
| Report | 1 |
| Reluctant | 1 |
| Related | 1 |
| Rekhtman | 1 |
| Rosenbach | 1 |
| Rotations | 1 |
| Sciences | 1 |
| Samie | 1 |
| Science | 1 |
| Schultz | 1 |
| School | 1 |
| Saudi | 1 |
| Sars | 1 |
| Sarah | 1 |
| Sao | 1 |
| Santamaría | 1 |
| Sanofi | 1 |
| Sandoz | 1 |
| Sanches | 1 |
| Sampling | 1 |
| Sakuraba | 1 |
| Ruiz | 1 |
| Saeki | 1 |
| ST | 1 |
| SLE | 1 |
| SCC | 1 |
| S9 | 1 |
| S8 | 1 |
| S5B | 1 |
| S4 | 1 |
| S3 | 1 |
| S2 | 1 |
| S10 | 1 |
| Ryan | 1 |
| -63 | 1 |